Bitao Bu

1095 Jiefang Ave
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.

Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.

Journal: Annals of clinical and translational neurology
Published: May 12, 2026

Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China.

Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China.

Journal: Neurology and therapy
Published: March 28, 2026

Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.

Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.

Journal: The American journal of case reports
Published: February 09, 2026

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

Journal: Journal of neurology
Published: November 20, 2025

Add-On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real-World Case Series.

Add-On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real-World Case Series.

Journal: Brain and behavior
Published: October 21, 2025

Assessing outer retinal and choroidal changes in scd: potential for high-risk screening using SS-OCTA.

Assessing outer retinal and choroidal changes in scd: potential for high-risk screening using SS-OCTA.

Journal: Translational psychiatry
Published: May 15, 2025

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Journal: Journal of clinical neurology (Seoul, Korea)
Published: May 08, 2025

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study.

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study.

Journal: Muscle & nerve
Published: March 25, 2025

The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis.

The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis.

Journal: Cellular immunology
Published: March 01, 2025

Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.

Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.

Journal: Therapeutic advances in neurological disorders
Published: December 10, 2024

Guillain-Barré Syndrome During the Outbreak of Omicron in Southern China: A Multicenter Case-Control Study.

Guillain-Barré Syndrome During the Outbreak of Omicron in Southern China: A Multicenter Case-Control Study.

Journal: Journal of inflammation research
Published: October 28, 2024

The JAK1/3 Inhibitor Tofacitinib Regulates Th Cell Profiles and Humoral Immune Responses in Myasthenia Gravis.

The JAK1/3 Inhibitor Tofacitinib Regulates Th Cell Profiles and Humoral Immune Responses in Myasthenia Gravis.

Journal: Muscle & nerve
Published: July 20, 2024
Showing 1-12 of 63

Last Updated: 09/26/2026